| 51 |
23103562 | TNF-α-mediated NF-κB survival signaling impairment by cisplatin enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells. | 2013 Jan 15 |
13 |
| 52 |
23625948 | The nuclear factor κB family member RelB facilitates apoptosis of renal epithelial cells caused by cisplatin/tumor necrosis factor α synergy by suppressing an epithelial to mesenchymal transition-like phenotypic switch. | 2013 Jul |
6 |
| 53 |
24151445 | TNF-α -857C>T genotype is predictive of clinical response after treatment with definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma. | 2013 |
2 |
| 54 |
21684138 | Sulforaphane, a natural constituent of broccoli, prevents cell death and inflammation in nephropathy. | 2012 May |
3 |
| 55 |
22010829 | Critical role of CD40-mediated autocrine tumor necrosis factor-alpha in potentiation of cisplatin-induced cytotoxicity in cancer cells. | 2012 Feb |
6 |
| 56 |
22316209 | Defining the molecular signature of chemotherapy-mediated lung tumor phenotype modulation and increased susceptibility to T-cell killing. | 2012 Feb |
1 |
| 57 |
22330679 | DR3 signaling protects against cisplatin nephrotoxicity mediated by tumor necrosis factor. | 2012 Apr |
1 |
| 58 |
21148032 | Activation of lipopolysaccharide-TLR4 signaling accelerates the ototoxic potential of cisplatin in mice. | 2011 Jan 15 |
1 |
| 59 |
21307147 | Phase I study of NGR-hTNF, a selective vascular targeting agent, in combination with cisplatin in refractory solid tumors. | 2011 Apr 1 |
1 |
| 60 |
20693797 | Transforming growth factor alpha stimulation of mucosal tissue cultures from head and neck squamous cell carcinoma patients increases chemoresistance to cisplatin. | 2010 |
2 |
| 61 |
19852930 | Association of caspase-8 mutation with chemoresistance to cisplatin in HOC313 head and neck squamous cell carcinoma cells. | 2009 Dec 18 |
1 |
| 62 |
17183590 | Antiapoptotic mechanism of cannabinoid receptor 2 agonist on cisplatin-induced apoptosis in the HEI-OC1 auditory cell line. | 2007 Mar |
1 |
| 63 |
17253597 | Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma. | 2007 Mar |
3 |
| 64 |
17516123 | Cisplatin cytotoxicity of auditory cells requires secretions of proinflammatory cytokines via activation of ERK and NF-kappaB. | 2007 Sep |
2 |
| 65 |
17597786 | Tumor necrosis factor-alpha in cisplatin nephrotoxicity: a homebred foe? | 2007 Jul |
3 |
| 66 |
23675041 | Celecoxib Enhances the Chemotherapeutic Response of Cisplatin and TNF-α in SiHa Cells through Reactive Oxygen Species-Mediated Mitochondrial Pathway. | 2007 Sep |
1 |
| 67 |
16376337 | NF-kappaB activation is required for cisplatin-induced apoptosis in head and neck squamous carcinoma cells. | 2006 Jan 9 |
4 |
| 68 |
16681749 | Analysis of differential protein expression by cisplatin treatment in cervical carcinoma cells. | 2006 Mar-Apr |
1 |
| 69 |
17050242 | Cisplatin increases TNF-alpha mRNA stability in kidney proximal tubule cells. | 2006 |
6 |
| 70 |
15700318 | Potential attenuation of p38 signaling by DDB2 as a factor in acquired TNF resistance. | 2005 Jun 20 |
2 |
| 71 |
21205524 | [Effects of recombinant human tumor-necrosis factor related to apoptosis inducing ligand protein on apoptosis of human lung adenocarcinoma cell line resistant to cisplatin]. | 2005 Oct 20 |
1 |
| 72 |
14734475 | Impairment of both apoptotic and cytoprotective signalings in glioma cells resistant to the combined use of cisplatin and tumor necrosis factor alpha. | 2004 Jan 1 |
1 |
| 73 |
15367711 | Chemoinducible gene therapy: a strategy to enhance doxorubicin antitumor activity. | 2004 Sep |
1 |
| 74 |
15461705 | Inflammatory cytokines in acute renal failure. | 2004 Oct |
5 |
| 75 |
12729367 | Cisplatin treatment triggers familial Mediterranean fever attacks. | 2003 Jan-Feb |
1 |
| 76 |
12965278 | Tumour necrosis factor alpha: a potential target for the therapy of solid tumours. | 2003 Sep |
1 |
| 77 |
12163460 | Transcriptional control of viral gene therapy by cisplatin. | 2002 Aug |
1 |
| 78 |
11451200 | Sensitization of human malignant glioma cell lines to tumor necrosis factor-induced apoptosis by cisplatin. | 2001 Mar |
3 |
| 79 |
11459199 | Sensitivity to topoisomerase I inhibitors and cisplatin is associated with epidermal growth factor receptor expression in human cervical squamous carcinoma ME180 sublines. | 2001 Jun |
1 |
| 80 |
10653982 | Increased ecto-metallopeptidase activity in cells undergoing apoptosis. | 2000 Jan |
1 |
| 81 |
10211553 | Cisplatin at clinically relevant concentrations enhances interleukin-2 synthesis by human primary blood lymphocytes. | 1999 Feb |
3 |
| 82 |
10339731 | A diary form quality of life questionnaire for Japanese patients with lung cancer and summarization techniques for longitudinal assessment. | 1999 Mar |
1 |
| 83 |
10440872 | Sensitization of immunoresistant prostate carcinoma cell lines to Fas/Fas ligand-mediated killing by cytotoxic lymphocytes: independence of de novo protein synthesis. | 1999 Sep 15 |
1 |
| 84 |
9703867 | Effect of interleukin-1 alpha and tumour necrosis factor-alpha on cisplatin-induced ERCC-1 mRNA expression in a human ovarian carcinoma cell line. | 1998 Jul-Aug |
1 |
| 85 |
9875677 | cis-Diamminedichloroplatinum and 5-fluorouracil are potent inducers of the cytokines and natural killer cell activity in vivo and in vitro. | 1998 Dec |
2 |
| 86 |
9084851 | Synergistic effect and possible mechanisms of tumor necrosis factor and cisplatin cytotoxicity under moderate hyperthermia against gastric cancer cells. | 1997 Mar |
4 |
| 87 |
9168934 | TNF-alpha mediates inducible nitric oxide synthase expression in human neuroblastoma cell line by cisplatin. | 1997 Apr 28 |
4 |
| 88 |
9222301 | Enhancement of tumor cell susceptibility to tumor-infiltrating lymphocytes by cisplatin. | 1997 |
4 |
| 89 |
8616765 | Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-alpha and cis-diamminedichloroplatinum. | 1996 Feb 15 |
4 |
| 90 |
10851495 | Augmentation of cisplatin cytotoxicity using cytokines on cervical carcinoma cell lines. | 1996 Dec |
2 |
| 91 |
21594505 | Tumor necrosis factor-alpha (TNF alpha) enhances cisplatin cytotoxicity to ovarian carcinoma xenografts. | 1996 Nov |
2 |
| 92 |
7539458 | Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. | 1995 Jun |
1 |
| 93 |
8044830 | Effect of interferon gamma and tumour necrosis factor alpha on sensitivity to cisplatin in ovarian carcinoma cell lines. | 1994 Aug |
3 |
| 94 |
8189599 | Overcoming TNF-alpha and drug resistance of human renal cell carcinoma cells by treatment with pentoxifylline in combination with TNF-alpha or drugs: the role of TNF-alpha mRNA downregulation in tumor cell sensitization. | 1994 Jun |
2 |
| 95 |
7684321 | Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins. | 1993 Jun 1 |
1 |
| 96 |
8334635 | Overcoming cis-diamminedichloroplatinum (II) resistance of human ovarian tumor cells by combination treatment with cis-diamminedichloroplatinum (II) and tumor necrosis factor-alpha. | 1993 Aug 1 |
14 |
| 97 |
21573353 | Overcoming tnf-alpha and cddp resistance of a human ovarian-cancer cell-line (c30) by treatment with buthionine sulfoximine in combination with tnf-alpha and or cddp. | 1993 Aug |
3 |
| 98 |
1380890 | Resistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin: evidence of a role for DNA repair and epidermal growth factor receptor. | 1992 Sep 1 |
1 |
| 99 |
1392402 | Activation of human peripheral-blood-derived monocytes by cis-diamminedichloroplatinum: enhanced tumoricidal activity and secretion of tumor necrosis factor-alpha. | 1992 May-Jun |
6 |
| 100 |
1401076 | Modulation of cisplatin sensitivity and growth rate of an ovarian carcinoma cell line by bombesin and tumor necrosis factor-alpha. | 1992 Oct |
1 |